Doxycycline hyclate 200 MG Delayed Release Oral Tablet — RxCUI 1423080
RxNorm drug concept · Semantic clinical drug
RxCUI 1423080
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
49 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1423080
Official nameDoxycycline hyclate 200 MG Delayed Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped18
Package NDCs mapped49
Reported Medicaid activity (SDUD)1,519 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The IV form is used when you're not able to swallow or absorb oral medication — for example, if you're too sick, vomiting, or need a faster, more reliable delivery of the antibioti...
- Why am I getting doxycycline through an IV instead of just taking a pill?
- It depends on what infection you're being treated for. For most infections, treatment continues for at least 24 to 48 hours after your fever and symptoms have cleared. For somethin...
- How long will I need to be on this antibiotic?
🕸️ Concept Web — How Doxycycline hyclate 200 MG Delayed Release Oral... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxycycline hyclate 200 MG Delayed Release Oral Tablet
RxCUI 1423080 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Doxycycline
3640IN -
Doxycycline hyclate
23663PIN
-
Doxycycline
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Doryx
216727BN
-
Doryx
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxycycline Delayed Release Oral Tablet
439221SCDF -
Doxycycline hyclate Delayed Release Oral Tablet
2648584SCDFP -
Doxycycline Oral Product
1160778SCDG -
Doxycycline Pill
1160779SCDG -
Doxycycline hyclate Oral Product
2663263SCDGP -
Doxycycline hyclate Pill
2661949SCDGP -
Doxycycline Delayed Release Oral Tablet [Doryx]
541950SBDF -
Doxycycline hyclate Delayed Release Oral Tablet [Doryx]
2656920SBDFP - +5 more in this family
-
Doxycycline Delayed Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxycycline hyclate 200 MG
1652669SCDC -
Doxycycline hyclate 200 MG Delayed Release Oral Tablet [Doryx]
1423082SBD -
Doxycycline hyclate 200 MG [Doryx]
1652671SBDC
-
Doxycycline hyclate 200 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxycycline hyclate 200 MG
SCDC · 1652669 -
Doxycycline Delayed Release Oral Tablet
SCDF · 439221 -
Doxycycline hyclate Delayed Release Oral Tablet
SCDFP · 2648584 -
Doxycycline Oral Product
SCDG · 1160778 -
Doxycycline Pill
SCDG · 1160779 -
Doxycycline hyclate Oral Product
SCDGP · 2663263 -
Doxycycline hyclate Pill
SCDGP · 2661949
Brand-Name Concepts
-
Doxycycline hyclate 200 MG Delayed Release Oral Tablet [Doryx]
SBD · 1423082 -
Doxycycline hyclate 200 MG [Doryx]
SBDC · 1652671 -
Doxycycline Delayed Release Oral Tablet [Doryx]
SBDF · 541950 -
Doxycycline hyclate Delayed Release Oral Tablet [Doryx]
SBDFP · 2656920 -
Doryx Oral Product
SBDG · 1175893 -
Doryx Pill
SBDG · 1175894 -
Doryx
BN · 216727
📦 FDA Products & Package NDCs
18 products · 49 package NDCs
49 package NDCs map to RxCUI 1423080 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-4550-22 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-4550-22) | Doxycycline Hyclate | Actavis Pharma, Inc. | 2019-08-14 |
| 00591-4575-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-4575-60) | Doxycycline Hyclate | Actavis Pharma, Inc. | 2019-08-14 |
| 23155-0141-01 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-141-01) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0141-05 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-141-05) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0141-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-141-06) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0142-01 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-142-01) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0142-05 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-142-05) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0143-01 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-143-01) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0143-04 | 250 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-143-04) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0143-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-143-06) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2013-04-30 |
| 23155-0611-04 | 250 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-611-04) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-03-16 |
| 23155-0611-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (23155-611-06) | DOXYCYCLINE HYCLATE DELAYED RELEASE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2018-03-16 |
| 43547-0324-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-324-06) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2016-11-28 |
| 43547-0324-10 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-324-10) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2016-11-28 |
| 43547-0324-50 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-324-50) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2016-11-28 |
| 43547-0325-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-325-06) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2016-11-28 |
| 43547-0325-10 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-325-10) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2016-11-28 |
| 43547-0325-50 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-325-50) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2016-11-28 |
| 43547-0462-12 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (43547-462-12) | DOXYCYCLINE HYCLATE | Solco Healthcare US LLC | 2018-11-28 |
| 46708-0481-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-481-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0481-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-481-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0481-91 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-481-91) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0482-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-482-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0482-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-482-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0482-91 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-482-91) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0483-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-30) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2023-03-07 |
| 46708-0483-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0483-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0483-71 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-483-71) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0484-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-30) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-10-15 |
| 46708-0484-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0484-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 46708-0484-71 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (46708-484-71) | Doxycycline Hyclate | Alembic Pharmaceuticals Limited | 2022-01-04 |
| 62332-0481-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-481-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0481-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-481-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0481-91 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-481-91) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0482-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0482-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0482-91 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-482-91) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0483-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-30) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2023-03-07 |
| 62332-0483-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0483-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0483-71 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-483-71) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0484-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-30) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-10-15 |
| 62332-0484-31 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-31) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0484-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-60) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 62332-0484-71 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (62332-484-71) | Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | 2022-01-04 |
| 68308-0716-30 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68308-716-30) | Doxycycline Hyclate | Mayne Pharma Commercial LLC | 2017-12-18 |
| 68308-0716-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68308-716-60) | Doxycycline Hyclate | Mayne Pharma Commercial LLC | 2016-02-01 |
Observed labelers:
Alembic Pharmaceuticals Inc. (14) ·
Alembic Pharmaceuticals Limited (14) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (10) ·
Solco Healthcare US LLC (7) ·
Actavis Pharma, Inc. (2) ·
Mayne Pharma Commercial LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.